Stock Events

Stock Events

Revelation Biosciences 

$1.1800
37
+$0.05+4.42% Friday 19:59
+$0.00+0%Friday 20:00After hours

Statistics

Day High
1.18
Day Low
1.1701
52W High
12.88
52W Low
0.875
Volume
7,986
Avg. Volume
-
Mkt Cap
4.61M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

7AugExpected
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Next
-45.44
-30.57
-15.7
-0.83
Expected EPS
-0.83
Actual EPS
N/A

Financials

-Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
0Revenue
-15.04MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow REVB. It's not an investment recommendation.
NVIDIA
6
NVDA
Tesla
5
TSLA
Broadcom
5
AVGO
Microsoft
4
MSFT

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Moderna
MRNA
Mkt Cap27.09B
Moderna is a leader in mRNA technology, competing in the biotech space with innovative treatments and vaccines that could overlap with Revelation Biosciences' therapeutic areas.
BioNTech
BNTX
Mkt Cap23.14B
BioNTech competes in the development of novel therapies and vaccines, directly challenging Revelation Biosciences in the innovative biopharmaceutical market.
Novavax
NVAX
Mkt Cap1.53B
Novavax is involved in the development of vaccines for infectious diseases, competing with Revelation Biosciences in the vaccine development space.
Pfizer
PFE
Mkt Cap137.76B
Pfizer is a large pharmaceutical company with a broad product portfolio that includes vaccines and therapies, competing across several of Revelation Biosciences' potential markets.
Johnson & Johnson
JNJ
Mkt Cap618.61B
Johnson & Johnson, through its pharmaceutical division Janssen, competes in the development of drugs and vaccines, covering areas that Revelation Biosciences may target.
Gilead Sciences
GILD
Mkt Cap161.19B
Gilead Sciences is known for its antiviral drugs, directly competing with Revelation Biosciences in the development of treatments for infectious diseases.
Regeneron Pharmaceuticals
REGN
Mkt Cap69.67B
Regeneron Pharmaceuticals competes in the biotechnology field, focusing on immunology and infectious diseases, areas of interest for Revelation Biosciences.
Vertex Pharmaceuticals
VRTX
Mkt Cap123.19B
Vertex Pharmaceuticals focuses on creating new treatments for serious diseases, potentially competing with Revelation Biosciences in drug development and innovation.
AMGEN
AMGN
Mkt Cap196.12B
Amgen is a biotech firm that develops innovative medicines, including for immune disorders, competing with Revelation Biosciences in the biopharmaceutical sector.
Astrazeneca
AZN
Mkt Cap266.15B
AstraZeneca is a global pharmaceutical company that develops vaccines and treatments for various diseases, competing with Revelation Biosciences in several therapeutic areas.

About

Revelation Biosciences, Inc. is a biopharmaceutical firm currently in its clinical development phase, dedicated to the advancement and commercialization of treatments and diagnostic tools targeting the immune system. The company's therapeutic pipeline includes promising candidates such as GEM-AKI, which is being developed as a potential therapy for both the prevention and management of acute kidney injury, and GEM-CKD, intended for the prevention and treatment of chronic kidney disease. Established in 2019, this San Diego, California-based enterprise was formerly known as Petra Acquisition, Inc., before officially adopting the name Revelation Biosciences, Inc. in January 2022.
Show more...
CEO
Mr. James M. Rolke
Employees
8
Country
United States
ISIN
US76135L8046

Listings

STU
DE
56U0.STU
STU
DE
56U1.STU
XNAS
US
REVB
XNAS
US
REVBW

0 Comments

Share your thoughts

FAQ

What is Revelation Biosciences stock price today?▼
The current price of REVB is $1.18 USD — it has increased by +4.42% in the past 24 hours. Watch Revelation Biosciences stock price performance more closely on the chart.
What is Revelation Biosciences stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Revelation Biosciences stocks are traded under the ticker REVB.
Is Revelation Biosciences stock price growing?▼
REVB stock has risen by +18% compared to the previous week, the month change is a +20.41% rise, over the last year Revelation Biosciences has showed a -90% decrease.
What is Revelation Biosciences market cap?▼
Today Revelation Biosciences has the market capitalization of 4.61M
When is the next Revelation Biosciences earnings date?▼
Revelation Biosciences is going to release the next earnings report on August 07, 2026.
What were Revelation Biosciences earnings last quarter?▼
REVB earnings for the last quarter are -2.71 USD per share, whereas the estimation was -2.71 USD resulting in a +0% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Revelation Biosciences revenue for the last year?▼
Revelation Biosciences revenue for the last year amounts to 0 USD.
What is Revelation Biosciences net income for the last year?▼
REVB net income for the last year is -15.04M USD.
How many employees does Revelation Biosciences have?▼
As of July 18, 2026, the company has 8 employees.
In which sector is Revelation Biosciences located?▼
Revelation Biosciences operates in the Health & Wellness sector.
When did Revelation Biosciences complete a stock split?▼
The last stock split for Revelation Biosciences was on January 28, 2026 with a ratio of 1:4.
Where is Revelation Biosciences headquartered?▼
Revelation Biosciences is headquartered in San Diego, United States.